Vesicular neurotransmitter transporters: Potential sites for the regulation of synaptic function

Molecular Neurobiology

Volumn 15, Issue 2, 1997, Pages 165-192

  Varoqui, Hélène ^a   Erickson, Jeffrey D ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Cholinergic gene locus; Gene knockout; Large dense core vesicles; Neurodegeneration; Neurotoxicity; Parkinson's disease; Small synaptic vesicles; Targeting; VAChT; Vesicular acetylcholine transporter; Vesicular monoamine transporter; VMAT1; VMAT2

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CARRIER PROTEIN; HELMINTH PROTEIN; HYBRID PROTEIN; NERVE PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; CAENORHABDITIS ELEGANS; CATTLE; CHEMICAL STRUCTURE; CHEMISTRY; CLASSIFICATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; MOUSE; MOUSE MUTANT; NERVE DEGENERATION; PHYSIOLOGY; PROTEIN CONFORMATION; RAT; REVIEW; SYNAPSE VESICLE; SYNAPTIC TRANSMISSION; TRANSPORT AT THE CELLULAR LEVEL;

AMINO ACID SEQUENCE; ANIMALS; BIOLOGICAL TRANSPORT; CAENORHABDITIS ELEGANS; CARRIER PROTEINS; CATTLE; GENE EXPRESSION REGULATION; HELMINTH PROTEINS; HUMANS; MICE; MICE, KNOCKOUT; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NEUROTRANSMITTER AGENTS; PROTEIN CONFORMATION; RATS; RECOMBINANT FUSION PROTEINS; SYNAPTIC TRANSMISSION; SYNAPTIC VESICLES;

EID: 0031240873     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02740633     Document Type: Article

References (192)

1. Agoston D. V., Conlon J. M., and Whittaker V. P. (1988) Selective depletion of the acetylcholine and vasoactive intestinal polypeptide of the guinea-pig myenteric plexus by differential mobilization of distinct transmitter pools. Exp. Brain Res. 72, 535-542.
2. Alfonso A., Grundahl K., Duerr J. S., Han H.-P., and Rand J. B. (1993) The Caenorhabditis elegans unc-27 gene: a putative vesicular acetylcholine transporter. Science 261, 617-619.
3. Alfonso A., Grundahl K., McManus J. R., Asbury J. M., and Rand J. B. (1994) Alternative splicing leads to two cholinergic proteins in Caenorhabditis elegans. J. Mol. Biol. 241, 627-630.
4. Amara S. and Kuhar M. J. (1992) Neurotransmitter transporters - recent progress. Ann. Rev. Neurosci. 16, 73-93.
5. + depolarization on choline kinase and choline acetyltranserase activities in superior cervical sympathetic ganglia excised from rats. J. Neurochem. 48, 1448-1453.
6. Asher S. W. and Aminoff M. J. (1981) Tetrabenazine and movement disorders. Neurology 31, 1051-1054.
7. Arvidsson U., Riedl M., Elde R., and Meister B. (1997) Vesicular acetylcholine transporter (VAChT) protein: a novel and unique marker for cholinergic neurons in the central and peripheral nervous systems. J. Comp. Neurol. 378, 454-467.
8. Axelrod J. (1971) Noradrenaline: fate and control of its biosynthesis. Science 173, 598-606.
9. Bahr B. A. and Parsons S. M. (1986) Acetylcholine transport and drug inhibition kinetics in Torpedo synaptic vesicles. J. Neurochem. 46, 1214-1218.
10. Bauerfeind R., Regnier-Vigouroux A., Flatmark T., and Huttner W. B. (1993) Selective storage of acetylcholine, but not catecholamines, in neuroendocrine synaptic-like microvesicles of early endosomal origin. Neuron 11, 105-121.
11. Bauerfeind R., Jelinek R., Hellwig A., and Huttner W. B. (1995) Neurosecretory vesicles can be hybrids of synaptic vesicles and secretory granules. Proc. Natl. Acad. Sci. USA 92, 7342-7346.
12. Béjanin S., Cervini R., Mallet J., and Berrard S. (1994) A unique gene organization for two cholinergic markers, choline acetyltransferase and a putative vesicular transporter of acetylcholine. J. Biol. Chem. 269, 21,944-21,947.
13. Ben-Shachar D., Zuk R., and Glinka Y. (1995) Dopamine neurotoxicity: inhibition of mitochondrial respiration. J. Neurochem. 64, 718-723.
14. Bennett M. K. and Scheller R. H. (1994) A molecular description of synaptic vesicle membrane trafficking. Ann. Rev. Biochem. 63, 63-100.
15. Berrard S., Varoqui H., Cervini R., Israël M., Mallet J., and Diebler M.-F. (1995) Coregulation of two embedded gene products, choline acetyltransferase and the vesicular acetylcholine transporter. J. Neurochem. 65, 939-942.
16. Berse B. and Blusztajn J. K. (1995) Coordinated up-regulation of choline acetyltransferase and vesicular acetylcholine transporter gene expression by the retinoic acid receptor α, cAMP, and leukemia inhibitory factor/ciliary neurotrophic factor signaling pathways in a murine septal cell line. J. Biol. Chem. 270, 22,101-22,104.
17. Blumberg D. and Schweitzer E. S. (1992) Vesamicol binding to subcellular membranes that are distinct from catecholaminergic vesicles in PC12 cells. J. Neurochem. 58, 801-810.
18. Blusztajn J. K. and Wurtman R. J. (1983) Choline and cholinergic neurons. Science 221, 614-619.
19. Boissière F., Faucheux B., Agid Y., and Hirsch E. C. (1997) Choline acetyltransferase mRNA expresion in the striatal neurons of patients with Alzheimer's disease. Neurosci. Lett. 225, 169-172.
20. Brenner S. (1974) The genetics of Caenorhabditis elegans. Genetics 77, 71-94.
21. Buu N. T. (1989) Modification of vesicular dopamine and norepinephrine by monoamine oxidase inhibitors. Biochem. Pharmacol. 38, 1685-1692.
22. Cameron P. L., Sudhof T. C., Jahn R., and de Camilli P. (1991) Colocalization of synaptophysin with transferrin receptors: implications for synaptic vesicle biogenesis. J. Cell Biol. 115, 151-164.
23. Cervini R., Berrard S., Béjanin S., and Mallet J. (1994) Regulation by CDF/LIF and retinoic acid of multiple ChAT mRNAs produced from distinct promoters. NeuroReport 5, 1346-1348.
24. Cervini R., Houhou L., Pradat P.-F., Béjanin S., Mallet J., and Berrard S. (1995) Specific vesicular acetylcholine transporter promoters lie within the first intron of the rat choline acetyltransferase gene. J. Biol. Chem. 270, 24,654-24,657.
25. Clarkson E., Rogers G., and Parsons S. (1992) Binding and active transport of large analogues of acetylcholine by cholinergic synaptic vesicles in vitro. J. Neurochem. 59, 695-700.
26. Clift-O'Grady L., Linstedt A. D., Lowe A. W., Grote E., and Kelly R. B. (1990) Biogenesis of synaptic vesicle-like structures in a pheochromocytoma cell line PC-12. J. Cell Biol. 110, 1693-1703.
27. Cohen E. L. and Wurtman R. J. (1975) Brain acetylcholine: increase after systemic choline administration. Life Sci. 16, 1095-1102.
28. Costa D. and Sandler M., eds. (1972) Monoamine Oxidases - New Vistas. Advances in Biochemical Psychopharmacology, vol. 5, Raven, New York.
29. Cubells J. F., Rayport S., Rajendran G., and Sulzer D. (1994) Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J. Neurosci. 14, 2260-2271.
30. Darchen F., Scherman D., Desnos C., and Henry J.-P. (1988) Characteristics of the transport of the quaternary ammonium 1-methyl-4-phenyl-pyridinium by chromaffin granules. Biochem. Pharmacol. 37, 4381-4387.
31. Darchen F., Scherman D., and Henry J.-P. (1989) Reserpine binding to chromaffin granules suggests the existence of two conformations of the monoamine transporter. Biochemistry 28, 1692-1697.
32. Davies P. and Maloney A. J. R. (1976) Selective loss of cholinergic neurons in Alzheimer's disease. Lancet 2, 1403.
33. Davis G. C., Williams A. C., Markey S. P., Ebert M. H., Caine E. D., Reichert C. M., and Kopin I. J. (1979) Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res. 1, 249-254.
34. De Giorgio R., Su D., Peter D., Edwards R. H., Brecha N. C., and Sternini C. (1996) Vesicular monoamine transporter 2 expression in enteric neurons and enterochromaffin-like cells of the rat. Neurosci Lett. 217, 77-80.
35. Desnos C., Laran M. P., and Scherman D. (1992) Regulation of the chromaffin granule catecholamine transporter in cultured bovine adrenal medullary cells: stimulus biosynthesis coupling. J. Neurochem. 59, 2105-2112.
36. Desnos C., Laran M.-P., Langley K., Aunis D., and Henry J.-P. (1995) Long term stimulation changes the vesicular monoamine transporter content of chromaffin granules. J. Biol. Chem. 270, 16,030-16,038.
37. Diebler M. F. and Morot Gaudry-Talarmain Y. (1989) AH5183 and cetiedil: two potent inhibitors of acetylcholine uptake into synaptic vesicles from Torpedo marmorata. J. Neurochem. 52, 813-821.
38. Diebler M. F. (1992) Effect of N-N′-dicyclohexylcarbodiimide on the binding of vesamicol, an inhibitor of acetylcholine transport into synaptic vesicles. Neurochem. Int. 21, 83-90.
39. Dimaline R. and Struthers J. (1996) Expression and regulation of a vesicular monoamine transporter in rat stomach: a putative histamine transporter. J. Physiol. 490, 249-256.
40. Disbrow J. K., Gershten M. J., and Ruth J. A. (1983) Immobilization of rat brain synaptic vesicles on positively-charged glass microspheres. Experientia 39, 623-625.
41. Dyrks T., Weidemann A., Multhaup G., Salbaum J. M., Lemaire H.-G., Kang J., Müller-Hill B., Masters C. L., and Beyreuther K. (1988) Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer's disease. EMBO J. 7, 949-957.
42. 3H]dopamine accumulation by synaptic vesicles purified from rat striatum: inhibition by thiocyanate ion. Brain Res. 516, 155-160.
43. Erickson J. D., Eiden L. E., and Hoffman B. (1992) Expression cloning of a reserpine-sensitive vesicular monoamine transporter. Proc. Natl. Acad. Sci. USA 89, 10,993-10,997.
44. Erickson J. D. and Eiden L. E. (1993) Functional identification and molecular cloning of a human brain vesicle monoamine transporter. J. Neurochem. 61, 2314-2317.
45. Erickson J. D., Varoqui H., Schäfer M. K.-H., Diebler M.-F., Weihe E., Modi W., Rand J. B., Eiden L. E., Bonner T. I., and Usdin T. (1994) Functional characterization of the mammalian vesicular acetylcholine transporter and its expression from a 'cholinergic' gene locus. J. Biol. Chem. 269, 21,929-21,932.
46. 3H-histamine by the neuronal isoform of the vesicular monoamine transporter. J. Mol. Neurosci. 6, 277-287.
47. Erickson J. D., Schäfer M. K.-H., Bonner T. I., Eiden L. E., and Weihe E. (1996a) Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc. Natl. Acad. Sci. USA 93, 5166-5171.
48. Erickson J. D., Weihe E., Schäfer J. K.-M., Neale E., Williamson L., Bonner T. I., Tao-Cheng J.-H., and Eiden L. E. (1996b) The VAChT/ChAT 'cholinergic gene locus': new aspects of genetic and vesicular regulation of cholinergic function. Prog. Brain Res. 109, 69-82.
49. Erickson J. D. (1997) A chimeric vesicular monoamine transporter dissociates sensitivity to tetrabenazine and unsubstituted aromatic amines. Adv. Pharmacol., in press.
50. Fahn S. and Cohen G. (1992) The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann. Neurol. 32, 804-812.
51. Feany M. B., Yee A. G., Delvy M. L., and Buckley K. M. (1993) The synaptic vesicle proteins SV2, synaptotagmin and synaptophysin are sorted to separate cellular compartments in CHO fibroblasts. J. Cell Biol. 123, 575-584.
52. Floor E., Leventhal P. S., Wang Y., Meng L., and Chen W. (1995) Dynamic storage of dopamine in rat brain synaptic vesicles in vitro. J. Neurochem. 64, 689-699.
53. Prize E. D. (1954) Mental depression in hypertensive patients treated for long periods with high doses of reserpine. N. Engl. J. Med. 251, 1006-1008.
54. Gasnier B., Scherman D., and Henry J.-P. (1985) Dicyclohexylcarbodiimide inhibits the monoamine carrier of bovine chromaffin granule membrane. Biochemistry 24, 1239-1244.
55. Gasnier B., Krejci E., Botton D., Massoulié J., and Henry J.-P. (1994) Expression of a bovine vesicular monoamine transporter in COS cells. FEBS Lett. 342, 225-229.
56. Gilmore M. L., Nash N. R., Roghani A., Edwards R. H., Yi H., Hersch S. M., and Levey A. I. (1996) Expression of the putative vesicular acetylcholine transporter in rat brain and localization in cholinergic synaptic vesicles. J. Neurosci. 16, 2179-2190.
57. Green L. A. and Rein G. (1977a) Synthesis, storage, and release of acetylcholine by a noradrenergic pheochromocytoma cell line. Nature 268, 349-351.
58. Green L. A. and Rein G. (1977b) Release, storage, and uptake of catecholamines by a clonal cell line of nerve growth factor (NGF) responsive pheochromocytoma cells. Brain Res. 129, 247-263.
59. Grote E., Hao J. C., Bennett M. K., and Kelly R. B. (1995) A targeting signal in VAMP regulating transport to synaptic vesicles. Cell 81, 581-589.
60. Geula C. and Mesulam M. M. (1989) Cortical cholinergic fibers in ageing and Alzheimer's disease: a morphometric study. Neuroscience 33, 469-476.
61. Harrington K. A., Augood S. J., Kingsbury A. E., Foster O. J. F., and Emson P. C. (1996) Dopamine transporter (DAT) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson's disease. Mol. Brain Res. 36, 157-162.
62. Henry J.-P., Gasnier B., Roisin M. P., Isambert M.-F., and Scherman D. (1987) Molecular pharmacology of the monoamine transporter of the chromaffin granule membrane. Ann. NY Acad. Sci. 493, 194-206.
63. Henry J.-P. and Scherman D. (1989) Radioligands of the vesicular monoamine transporter and their use as markers of the monoamine storage vesicles. Biochem. Pharmacol. 38, 2395-2404.
64. Henry J.-P., Sagné C., Botton D., Isambert M.-F., and Gasnier B. (1997) Molecular pharmacology of the vesicular monoamine transporter. Adv. Pharmacol., in press.
65. Haubrich D. R., Wang P. F. L., Clody D. E., and Wedeking P. W. (1975) Increase in rat brain acetylcholine induced by choline or deanol. Life Sci. 17, 975-980.
66. Howell M., Shirvan A., Stern-Bach Y., Steiner-Mordoch S., Strasser J. E., Dean G. E., and Schuldiner S. (1994) Cloning and functional expression of a tetrabenazine sensitive vesicular monoamine transporter from bovine chromaffin granules. FEBS Lett. 338, 16-22.
67. Jahn R., Schiebler W., Ouimet C., and Greengard P. (1985) A 38,000 dalton membrane protein (p38) is present in synaptic vesicles. Proc. Natl. Acad. Sci. USA 82, 4137-4141.
68. Jahn R. and Südhof T. C. (1993) Synaptic vesicle traffic: rush hour in the nerve terminal. J. Neurochem. 61, 12-21.
69. Javitch J., D'Amato R., Nye J., and Javitch J. (1985) Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. USA 82, 2173-2177.
70. Jenner P. and Olanow C. W. (1996) Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 47 (6 Suppl. 3), S161-S170.
71. Johnson R. (1988) Accumulation of biological amines in chromaffin granules: a model for hormone and neurotransmitter transport. Physiol. Rev. 68, 232-307.
72. Kanner B. I. and Bendahan A. (1985) Transport of 5-hydroxytryptamine in membrane vesicles from rat basophilic leukemia cells. Biochim. Biophys. Acta 816, 403-410.
73. Kanner B. I. and Schuldiner S. (1987) Mechanism of transport and storage of neurotransmitters. CRC Crit. Rev. Biochem. 22, 1-38.
74. Kelly R. B. (1993) Storage and release of neurotransmitters. Cell 72, 43-53.
75. Kelly R. B. and Grote E. (1993) Protein targeting in the neuron. Ann. Rev. Neurosci. 16, 95-127.
76. Kengaku M., Misawa H., and Deguchi T. (1993) Multiple mRNA species of choline acetyltransferase from rat spinal cord. Mol. Brain Res. 18, 71-76.
77. 3H-vesamicol binding in human brain cholinergic deficiency disorders. Neurosci. Lett. 117, 347-352.
78. Kitayama S., Shimada S., Xu H., Markham L., Donovan D. M., and Uhl G. R. (1992) Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Proc. Natl. Acad. Sci. USA 89, 7782-7785.
79. Kleven M. S., Schuster C. R., and Seiden L. S. (1988) Effect of depletion of brain serotonine by repeated fenfluramine on neurochemical and anorectic effects of acute fenfluramine. J. Pharmacol. Exp. Therap. 246, 822-828.
80. Kriepper S. M., Grunewald G. L., and Rutledge C. O. (1988) Inhibition of norepinephrine transport into synaptic vesicles by amphetamine analogs. J. Pharmacol. Exp. Ther. 217, 487-494.
81. +-linked dopamine transport in chromaffin granule ghosts. Biochemistry 20, 6625-6629.
82. Kölby L., Wängberg B., Ahlman H., Jansson S., Forssell-Aronsson E., Erickson J. D., and Nilsson O. (1997) Gastric carcinoid with histamine production, histamine transporter and expresion of somatostatin receptors. Digestion, in press.
83. Kornreich W. D. and Parsons S. M. (1988) Sidedness and chemical properties of the vesamicol receptor of cholinergic synaptic vesicles. Biochemistry 27, 5262-5267.
84. Koshimura K., Miwa S., Lee K., Hayashi Y., Hasegawa H., Hamahata K., Fujiwara M., Kimura M., and Itokawa Y. (1990) Effects of choline administration on in vivo release and biosynthesis of acetylcholine in the rat striatum as studied by in vivo brain microdialysis. J. Neurochem. 54, 533-539.
85. Krejci E., Gasnier B., Botton D., Isambert M.-F., Sagné C., Gagnon J., Massoulié J., and Henry J.-P. (1994) Expression and regulation of the bovine vesicular monoamine transporter gene. FEBS Lett. 335, 27-32.
86. Kuhl D. E., Minoshima S., Fessier J. A., Frey K. A., Foster N. L., Ficaro E. P., Wieland D. M., and Koeppe R. A. (1996) In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Ann. Neurol. 40, 399-410.
87. Langston J. W., Ballard P., Tetrud J. W., and Irwin L. (1983) Chronic parkinsonism in humans due to a product of meperidine analog synthesis. Science 219, 979-980.
88. Lehericy S., Brandel J.-P., Hirch E. C., Anglade P., Villares J., Scherman D., Duyckaerts C., Javoy-Agid F., and Agid Y. (1994) Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by titrated dihydrotetrabenazine autoradiography. Brain Res. 659, 1-9.
89. Lesch K. P., Gross J., Wolozin B. L., Franzek E., Bengel D., Riederer P., and Murphy D. L. (1994) Direct sequencing of the reserpine-sensitive vesicular monoamine transporter complementary DNA in unipolar depression and manic depressive illness. Psychiatr. Genet. 4, 153-160.
90. Linstedt A. D. and Kelly R. B. (1991a) Endocytosis of the synaptic vesicle protein, synaptophysin, requires the COOH-terminal tail. J. Physiol. (Paris) 85, 90-96.
91. Linstedt A. D. and Kelly R. B. (1991b) Synaptophysin is sorted from endocytotic markers in neuroendocrine PC12 cells but not transfected fibroblasts. Neuron 7, 309-317.
92. + toxicity encodes a vesicular amine transporter. Cell 70, 539-551.
93. +. Proc. Natl. Acad. Sci. USA 89, 9074-9078.
94. Liu Y., Schweitzer E., Nirenberg M. J., Pickel W. M., Evans C. J., and Edwards R. H. (1994) Preferential localization of a vesicular monoamine transporter to dense core vesicles in PC12 cells. J. Cell Biol. 127, 1419-1433.
95. Lundberg J. M., Franco-Cereceda A., Lou Y. P., Modin A., and Pernow J. (1994) Differential release of classical transmitters and peptides, in Molecular and Cellular Mechanisms of Neurotransmitter Release (Stjarne L., Greengard P., Grillner S., Hokfelt T., and Ottoson D., eds.), Raven, New York, pp. 223-234.
96. Mahata S. K., Mahata M., Fischer-Colbrie R., and Winkler H. (1993) Vesicle monoamine transporters 1 and 2: differential distribution and regulation of their mRNAs in chromaffin and ganglion cells of rat adrenal medulla. Neurosci. Lett. 156, 70-72.
97. Maire J.-C. and Wurtman R. J. (1985) Effects of electrical stimulation and choline availability on the release and contents of acetylcholine and choline in superfused slices from rat striatum. J. Physiol. (Paris) 80, 189-195.
98. Mandel M. R. and Klerman G. L. (1978) Clinical use of antidepressants, stimulants, tricyclics and monoamine oxidase inhibitors, in Principles of Psychopharmacology, 2nd ed. (Clark W. G. and del Guidice J., eds.), Academic, New York, pp. 537-551.
99. Marshall I. and Parsons S. (1987) The vesicular acetylcholine transport system. Trends Neurosci. 10, 174-177.
100. Matteoli M., Hainmann C., Torri-Tarelli F., Polak J. M., Ceccarelli B., and De Camilli P. (1988) Differential effect of α-latrotoxin on exocytosis from small synaptic vesicles and from large dense-core vesicles containing calcitonin gene-related peptide at the frog neuromuscular junction. Proc. Natl. Acad. Sci. USA 85, 7366-7370.
101. Maycox P. R., Hell J. W., and Jahn R. (1990) Amino acid neurotransmission: spotlight on synaptic vesicles. Trends Neurosci. 13, 83-87.
102. McMillen B. A., German D. C., and Shore P. A. (1980) Functional and pharmacological significance of brain dopamine and norepinephrine storage pools. Biochem. Pharmacol. 29, 3045-3050.
103. Meltzer H. Y. and Stahl S. M. (1976) The dopamine hypothesis of schizophrenia: a review. Schizophr. Bull. 2, 19-76.
104. Merickel A. and Edwards R. H. (1995) Transport of histamine by vesicular monoamine transporter-2. Neuropharmacology 34, 1543-1547.
105. Merickel A., Rosandich P., Peter D., and Edwards R. H. (1995) Identification of residues involved in substrate recognition by a vesicular monoamine transporter. J. Biol. Chem. 270, 25,798-25,804.
106. Misawa H., Shoji-Kasia Y., Takahashi R., Sugiyama T., Takagi H., Yoshida A., Yoshioka T., and Takahashi M. (1994) Storage and release of acetylcholine from PC12 cells expressing mouse choline acetyltransferase cDNA. Soc. Neurosci. Abstr. 20, 890.
107. Misawa H., Takahashi R., and Deguchi T. (1995) Coordinate expression of vesicular acetylcholine transporter and choline acetyltransferase in sympathetic superior cervical neurones. NeuroReport 6, 965-968.
108. Mundigl O. and De Camilli P. (1994) Formation of synaptic vesicles. Curr. Opin. Cell Biol. 6, 561-567.
109. Navone F., Jahn R., Di Gioia G., Stukenbrok H., Greengard P., and De Camilli P. (1986) Protein p38: an integral membrane protein specific for small vesicles of neurons and neuroendocrine cells. J. Cell Biol. 103, 2511-2527.
110. Nirenberg M. J., Liu Y., Peter D., Edwards R. H., and Pickel V. M. (1995) The vesicular monoamine transporter 2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei. Proc. Natl. Acad. Sci. USA 92, 8773-8777.
111. Nirenberg M. J., Chan J., Liu Y., Edwards R. H., and Pickel V. M. (1996) Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: potential sites for somatodendritic storage and release of dopamine. J. Neurosci. 16, 4135-4145.
112. Njus D., Kelley P. M., and Harnadek G. J. (1986) Bioenergetics of secretory vesicles. Biochim. Biophys. Acta 853, 237-265.
113. Nguyen M. L. and Parsons S. M. (1996) Interactions of protons with the acetylcholine transporter of synaptic vesicles. Prog. Brain Res. 109, 97-103.
114. Paxinos G. and Butcher L. L. (1985) Organizational principles of the brain as revealed by choline acetyltransferase and acetykholinesterase distribution and projections, in The Rat Nervous System vol. 1 (Paxinos G., ed.), Academic, New York, pp. 487-521.
115. Parsons S. M., Prior C., and Marshall I. G. (1993) Acetylcholine transport, storage, and release. Int. Rev. Neurobiol. 35, 279-390.
116. Patrick R. L. and Kirshner N. (1971) Effect of stimulation on the levels of tyrosine hydroxylase, dopamine β-hydroxylase, and catecholamines in intact and denervated rat adrenal glands. Mol. Pharmacol. 7, 87-96.
117. Pepeu G., Casamenti G., Pepeu I. M., and Scali C. (1993) The brain cholinergic system in ageing mammals. J. Reprod. Fert., Suppl. 46, 155-162.
118. Percisco A. M., Wang Q. W., Black D. W., Andreasen N. C., Uhl G. R., and Crowe R. R. (1996) Exclusion of close linkage between the synaptic vesicular monoamine transporter locus and schizophrenia spectrum disorders. Am. J. Med. Gen. 60, 563-565.
119. Perry E. K., Perry R. H., Blessed G., and Tomlinson B. E. (1977) Necropsy evidence of central cholinergic deficits in senile dementia. Lancet 1, 189.
120. Perry E. K., Tomlinson B. E., Blessed G., Bergmann K., Gibson P. H., and Perry R. H. (1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br. Med. J. 2, 1457-1459.
121. Peter D., Finn J. P., Klisak I., Liu Y., Kojis T., Heinzmann C., Roghani A., Sparkes R. S., and Edwards R. H. (1993) Chromosomal localization of the human vesicular amine transporter genes. Genomics 18, 720-723.
122. Peter D., Jimenez J., Liu Y., Kim J., and Edwards R. H. (1994) The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors. J. Biol. Chem. 269, 7231-7237.
123. Peter D., Liu Y., Sternini C., de Giorgio R., Brecha N., and Edwards R. H. (1995) Differential expression of two vesicular monoamine transporters. J. Neurosci. 15, 6179-6188.
124. Peter D., Vu T., and Edwards R. H. (1996) Chimeric vesicular monoamine transporters identify structural domains that influence substrate affinity and sensitivity to tetrabenazine. J. Biol. Chem. 271, 2979-2986.
125. Phillips J. H. (1982) Dynamic aspects of chromaffin granule structure. Neuroscience 7, 1595-1609.
126. Philippu A. and Beyer J. (1973) Dopamine and noradrenaline transport into subcellular vesicles of the striatum. Naunyn-Schmiedeberg's Arch. Pharmacol. 278, 387-402.
127. Ramsay R. R. and Singer T. P. (1986) Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by mitochondria. J. Biol. Chem. 261, 7585-7587.
128. Reinhard J. F., Daniels A. J., and Viveros O. H. (1988) Potentiation by reserpine and tetrabenazine of brain catecholamine depletions by MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) in the mouse; evidence for subcellular sequestration as basis for cellular resistance to the toxicant. Neurosci. Lett. 90, 349-353.
129. Régnier-Vigoureux A., Tooze S. A., and Huttner W. B. (1991) Newly synthesized synaptophysin is transported to synaptic like microvesicles via constitutive secretory vesicles and the plasma membrane. EMBO. J. 10, 3589-3601.
130. Régnier-Vigouroux A. and Huttner W. B. (1993) Biogenesis of small synaptic vesicles and synaptic-like microvesicles. Neurochem. Res. 18, 59-64.
131. Ricaurte G. A., Guillery R. W., Seiden L. S., Schuster C. R., and Moore R. Y. (1982) Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res. 235, 93-103.
132. Ricaurte G. A., Bryan G., Strauss L., Seiden L. S., and Schuster C. R. (1985) Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals. Science 229, 986-988.
133. Ricaurte G. A., DeLanney L. E., Irwin I., and Langston J. W. (1988) Toxic effect of MDMA on central serotonergic neurons in the primate: Importance of the route and frequency of drug administration. Brain Res. 446, 165-168.
134. Roghani A., Feldman J., Kohan S. A., Shirzadi A., Gundersen C. B., Brecha N., and Edwards R. H. (1994) Molecular cloning of a putative vesicular transporter for acetylcholine. Proc. Natl. Acad. Sci. USA 91, 10,620-10,624.
135. Rossor M. N., Garret N. J., Johnson A. L., Mountjoy C. Q., Roth M., and Iversen L. L. (1982) A post-mortem study of the cholinergic and GABA systems in senile dementia. Brain 105, 313-330.
136. 3H]vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions. Neuroscience 35, 327-333.
137. + pumping into intracellular organelles. Ann. Rev. Physiol. 48, 403-413.
138. Rudnick G., Steiner-Mordoch S. S., Fishkes H., Stern-Bach Y., and Schuldiner S. (1990) Energetics of reserpine binding and occlusion by the chromaffin granule transporter. Biochemistry 29, 603-608.
139. Rudnick G. and Wall S. C. (1992) The molecular mechanism of 'ecstasy' [3,4-methylenedioxymethamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc. Natl. Acad. Sci. USA 89, 1817-1821.
140. Sagné C., Isambert M.-F., Vanderckhove J., Henry J.-P., and Gasnier B. (1997) The photoactivable inhibitor 7-azido-8-iodoketanserin labels the N terminus of the vesicular monoamine transporter from bovine chromaffin granules. Biochemistry 36, 3345-352.
141. Schäfer M. K.-H., Weihe E., Varoqui H., Eiden L. E., and Erickson J. D. (1994) Distribution of the vesicular acetylcholine transporter (VAChT) in the central and peripheral nervous systems of the rat. J. Mol. Neurosci. 5, 1-18.
142. Schäfer M. K.-H., Weihe E., Erickson J. D., and Eiden L. E. (1995) Human and monkey cholinergic neurons visualized in paraffin-embedded tissues by immunoreactivity for VAChT, the vesicular acetylcholine transporter. J. Mol. Neurosci. 6, 225-235.
143. Schäfer M. K.-H., Schütz B., Erickson J. D., Eiden L. E., and Weihe E. (1996) Visualization of vesicular monoamine and acetylcholine transporters in developing neurons and neuroendocrine cells. Soc. Neurosci. Abstr. 22, 29.
144. Schäfer M. K.-H., Schutz B., Weihe E., and Eiden L. E. (1997) Target independent cholinergic differentiation in the rat sympathetic nervous system. Proc. Natl. Acad. Sci. USA 94, 4149-4154.
145. Scherman D. and Henry J.-P. (1984) Reserpine binding to bovine chromaffin granule membranes. Characterization and comparison with dihydrotetrabenazine binding. Mol. Pharmacol. 25, 113-122.
146. Scherman D. and Boschi G. (1988) Time required for transmitter accumulation inside monoaminergic storage vesicles differs in peripheral and in central systems. Neuroscience 27, 1029-1035.
147. Schubert D. and Klier F. G. (1977) Storage and release of acetylcholine by a clonal cell line. Proc. Natl. Acad. Sci. USA 74, 5184-5188.
148. Schuldiner S., Steiner-Mordoch S., Yelin R., Wall S. C., and Rudnick G. (1993a) Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters. Mol. Pharmacol. 44, 1227-1231.
149. Schuldiner S., Liu Y., and Edwards R. H. (1993b) Reserpine binding to a vesicular amine transporter expressed in chinese hamster ovary fibroblasts. J. Biol. Chem. 268, 29-34.
150. Schuldiner S., Shirvan A., and Linial M. (1995) Vesicular neurotransmitter transporters: from bacteria to humans. Physiol. Rev. 75, 369-392.
151. Shirvan A., Laskar O., Steiner-Mordoch S., and Schuldiner S. (1994) Histidine-419 plays a role in energy coupling in the vesicular monoamine transporter from rat. FEBS Lett. 356, 145-150.
152. Seiden L. S. and Sabol K. E. (1996) Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction. NIDA Res. Monogr. 163, 251-276.
153. Sietzen M., Schober M., Fischer-Colbrie R., Scherman D., Sperk G., and Winkler H. (1987) Rat adrenal medulla: levels of chromogranins, enkephalins, dopamine β-hydroxylase and of the amine transporter are changed by nervous activity and hypophysectomy. Neuroscience 22, 131-139.
154. Sievert M. K. and Ruoho A. E. (1996) Identification of drug binding sites on the synaptic vesicle monoamine translocator. FASEB J. 10, A1233 (abstract #1350).
155. Silva N. L. and Bunney B. S. (1988) Intracellular studies of dopamine neurons in vitro: pacemakers modulated by dopamine. Eur. J. Pharmacol. 149, 307-315.
156. Slotkin T. A., Nemeroff C. B., Bissette G., and Seidler F. J. (1994) Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease. J. Clin. Invest. 94, 696-702.
157. Song H.-J., Ming G.-L., Fon E., Bellocchio E., Edwards R. H., and Poo M.-M. (1997) Expression of a putative vesicular acetylcholine transporter facilitates quantal transmitter packaging. Neuron 18, 815-826.
158. Stachowiak M. K., Hong J. S., and Viveros O. H. (1990) Coordinate and differential regulation of phenylethanolamine N-methyltransferase, tyrosine hydroxylase and proenkephalin mRNAs by neural and hormonal mechanisms in cultured bovine adrenal medullary cells. Brain Res. 510, 277-288.
159. Steiner-Mordoch S., Shirvan A., and Schuldiner S. (1996) Modification of the pH profile and tetrabenazine sensitivity of rat VMAT1 by replacement of aspartate 404 with glutamate. J. Biol. Chem. 271, 13,048-13,054.
160. Strada O., Vyas S., Hirsch E. C., Rugerg M., Brice A., Agid Y., and Jovoy-Agid F. (1992) Decreased choline acetyltransferase mRNA expression in the nucleus basalis of Meynert in Alzheimer disease: An in situ hybridization study. Proc. Natl. Acad. Sci. USA 89, 9549-9553.
161. Strader C. D., Sigal C. D., Candelore M. R., Rands E., Hill W. S., and Dixon R. A. F. (1988) Conserved aspartic acid residues-79 and 113 of the β-adrenergic receptor have different roles in receptor function. J. Biol. Chem. 263, 10,267-10,271.
162. Strader C. D., Candelore M. R., Hill W. S., Sigal I. S., and Dixon R. A. F. (1989) Identification of two serine residues involved in agonist activation of the β-adrenergic recoptor. J. Biol. Chem. 264, 13,572-13,578.
163. Sulston J., Dew M., and Brenner S. (1975) Dopaminergic neurons in the nematode Caenorhabditis elegans. J. Comp. Neur. 163, 215-226.
164. Sulzer D. and Rayport S. (1990) Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Neuron 5, 797-808.
165. Surratt C. K., Persico A. M., Yang X.-D., Edgar S. R., Bird G. S., Hawkins A. L., Griffin C. A., Li X., Jabs E. W., and Uhl G. A. (1993) A human synaptic vesicle monoamine transporter cDNA predicts postranslational modifications, reveals chromosome 10 gene localization and identifies TaqI RFLPs. FEBS Lett. 318, 325-330.
166. Takahashi N., Miner L. L., Sora I., Ujike I., Revay R. S., Kostic V., Jackson-Lewis V., Przedborski S., and Uhl G. R. (1997) VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion and enhanced MPTP toxicity. Proc. Natl. Acad Sci. USA 94, 9938-9943.
167. Takimoto G. S., Stittworth J. D., Bianchi B. R., and Stephens J. K. (1983) Differential sensitivity of hypothalamus norepinephrine and striatal dopamine to catecholamine depleting agents. J. Pharmacol. Exp. Ther. 226, 432-439.
168. Tanner V. A., Ploug T., and Tao-Cheng J.-H. (1996) Subcellular localization of SV2 and other secretory vesicle components in PC12 cells by an efficient method of preembedding EM immunocytochemistry for cell cultures. J. Histochem. Cytochem. 44, 1481-1488.
169. Thureson-Klein A. K., Klein R. L., Zhu P.-C., and Kong J.-Y. (1988) Differential release of transmitters and neuropeptides co-stored in central and peripheral neurons, in Cellular and Molecular Basis of Synaptic Transmission (Zimmermann H., ed.), Springer-Verlag, Berlin, pp. 137-151.
170. Thoenen H., Mueller R. A., and Axelrod J. (1969) An enzymatic assay for octopamine and other β-hydroxylated phenylethylamines. J. Pharmacol. Exp. Ther. 160, 249-253.
171. Thoenen H. (1974) Trans-synaptic enzyme induction Life Sci. 14, 223-235.
172. Tian X., Sun X., and Suszkiw J. B. (1996) Developmental age-dependent upregulation of choline acetyltransferase and vesicular acetylcholine transporter mRNA expression in neonatal rat septum by nerve growth factor. Neurosci. Lett. 201, 134-136.
173. Ulus I., Wurtman R. J., Mauron C., and Blusztajn J. K. (1989) Choline increases acetylcholine release and protects against the stimulation-induced decrease in phosphatide levels within membranes of rat corpus striatum. Brain Res. 484, 217-227.
174. Unsicker K., Hofman H. D., Höhne I., Müller T. H., and Schmidt R. (1983) Phenotypic plasticity of cultured bovine chromaffin cells. II. Fiber outgrowth induced by elevated potassium: morphology and ionic requirements. Dev. Brain Res. 9, 369-379.
175. Usdin T. B., Eiden L. E., Bonner T. I., and Erickson J. D. (1995) Molecular biology of the vesicular ACh transporter. TINS 18, 218-224.
176. van Praag H. M. (1978) Amine hypothesis of affective disorders, in Handbook of Psychopharmacology, vol. 13, (Iversen L. L., Iversen S. D., and Snyder S. H., eds.), Plenum, New York, pp. 187-297.
177. Varoqui H., Diebler M.-F., Meunier F.-M., Rand J. B., Usdin T. B., Bonner T. I., Eiden L. E., and Erickson J. D. (1994) Cloning and expression of the vesamicol binding protein from the marine ray Torpedo. Homology with the putative vesicular acetylcholine transporter UNC-17 from Caenorhabditis elegans. FEBS Lett. 342, 97-102.
178. Varoqui H., Meunier F.-M., Meunier F. A., Molgo J., Berrard S., Cervini R., Mallet J., Israel M., and Diebler M.-F. (1996) Expression of the vesicular acetylcholine transporter in mammalian cells. Prog. Brain Res. 109, 83-95.
179. Varoqui H. and Erickson J. D. (1996a) Active transport of acetylcholine by the human vesicular acetylcholine transporter. J. Biol. Chem. 271, 27,229-27,232.
180. Varoqui H. and Erickson J. D. (1996b) Targeting of the human vesicular monoamine and acetylcholine transporters to secretory organelles in rat PC-12 cells. Soc. Neurosci. Abstr. 22, 149.
181. Varoqui H. and Erickson J. D. (1997) Vesicular transporter chimeras identify domains important for acetylcholine transport and targeting to synaptic vesicles. Soc. Neurosci. Abst., in press.
182. Weaver J. H. and Dupree J. D. (1982) Conditions required for reserpine binding to the catechola-mine transporter on chromaffin granule ghosts. Eur. J. Pharmacol. 80, 437-438.
183. Weihe E., Schäfer M. K.-H., Erickson J. D., and Eiden L. E. (1994) Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat. J. Mol. Neurosci. 5, 149-164.
184. Weihe E., Tao-Cheng J.-H., Schäfer M. K.-H., Erickson J. D., and Eiden L. E. (1996) Visualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesicles. Proc. Natl. Acad. Sci. USA 93, 3547-3552.
185. Weiner N. (1985) Norepinephrine, epinephrine, and the sympathomimetic amines, in The Pharmacological Basis of Therapeutics (Gilman A. G., Goodman L. S., and Gilman A., eds.), MacMillan, New York, pp. 138-175.
186. West A. E., Provoda C., Neve R. L., and Buckley K. M. (1997) Protein targeting in neurons and endocrine cells. Adv. Pharmacol, in press.
187. Whitehouse P. J., Price D. L., Clark A. W., Coyle J. T., and DeLong M. R. (1981) Alzheimer disease: evidence for a selective loss of cholinergic neurons in the nucleus basalis. Ann. Neurol. 10, 122-126.
188. Wilson J. M., Levey A. I., Rajput A., Ang L., Guttman M., Shannak K., Niznik H. B., Hornykiewicz O., Pifl C., and Kish S. J. (1996) Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease. Neurology 47, 718-726.
189. Wurtman R. J. (1992) Choline metabolism as a basis for the selective vulnerability of cholinergic neurons. TINS 15, 117-122.
190. + antiporter of Escherichia coli encoded by transposon Tn10: roles of the aspartyl residues located in the putative transmembrane helices. J. Biol. Chem. 267, 7490-7498.
191. + antiporter of Escherichia coli. FEBS Lett. 307, 229-232.
192. Yelin R. and Schuldiner S. (1995) The pharmacological profile of the vesicular monoamine transporter resembles that of multidrug transporters. FEBS Lett. 377, 201-207.